DK559487D0 - Anvendelse af etodolac til haemning af ankylose i led - Google Patents

Anvendelse af etodolac til haemning af ankylose i led

Info

Publication number
DK559487D0
DK559487D0 DK559487A DK559487A DK559487D0 DK 559487 D0 DK559487 D0 DK 559487D0 DK 559487 A DK559487 A DK 559487A DK 559487 A DK559487 A DK 559487A DK 559487 D0 DK559487 D0 DK 559487D0
Authority
DK
Denmark
Prior art keywords
etodolac
ankylosis
inhibit
led
application
Prior art date
Application number
DK559487A
Other languages
English (en)
Other versions
DK559487A (da
Inventor
Paul Hastings Wooley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of DK559487D0 publication Critical patent/DK559487D0/da
Publication of DK559487A publication Critical patent/DK559487A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK559487A 1986-10-27 1987-10-26 Anvendelse af etodolac til haemning af ankylose i led DK559487A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/923,373 US4710511A (en) 1986-10-27 1986-10-27 Etodolac for inhibition of joint ankylosis

Publications (2)

Publication Number Publication Date
DK559487D0 true DK559487D0 (da) 1987-10-26
DK559487A DK559487A (da) 1988-04-28

Family

ID=25448579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK559487A DK559487A (da) 1986-10-27 1987-10-26 Anvendelse af etodolac til haemning af ankylose i led

Country Status (8)

Country Link
US (1) US4710511A (da)
EP (1) EP0266114B1 (da)
JP (1) JP2585638B2 (da)
KR (1) KR950013755B1 (da)
AT (1) ATE96666T1 (da)
DE (1) DE3788035T2 (da)
DK (1) DK559487A (da)
ES (1) ES2059392T3 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533551A (en) * 1984-02-17 1985-08-06 American Home Products Corporation Method of treating arthritis with etodolac

Also Published As

Publication number Publication date
US4710511A (en) 1987-12-01
JP2585638B2 (ja) 1997-02-26
EP0266114A3 (en) 1990-05-09
JPS63126822A (ja) 1988-05-30
DE3788035T2 (de) 1994-03-03
KR880004813A (ko) 1988-06-27
ES2059392T3 (es) 1994-11-16
KR950013755B1 (ko) 1995-11-15
EP0266114B1 (en) 1993-11-03
EP0266114A2 (en) 1988-05-04
DE3788035D1 (de) 1993-12-09
DK559487A (da) 1988-04-28
ATE96666T1 (de) 1993-11-15

Similar Documents

Publication Publication Date Title
DK104292D0 (da) Heterocycliske forbindelser og fremgangsmaade til deres fremstilling
DK588486D0 (da) Anvendelse af en forbindelse til behandling af hypoxi
BG60249B1 (bg) Тиазолово съединение за лечение на язви
DE3579760D1 (de) Erzeugung von anaerobischen oder mikroaerophilischen bedingungen.
FI80906B (fi) Foerfarande foer extraktion av intakt rekombinant-human-immuninterferonprotein.
EP0223257A3 (en) Hair stabilizing composition
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
ZA878055B (en) A therapeutically useful compound
SE8603051L (sv) Enzympreparation med formaga att bryta ned glykosaminoglykan, samt sett for framstellning av preparationen
DK559487A (da) Anvendelse af etodolac til haemning af ankylose i led
HUT63734A (en) Fish-breeding method
DE3583625D1 (de) Erzeugung von bauholz.
ATE78686T1 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
FR2574838B1 (fr) Perfectionnements apportes aux poutres en i essentiellement constituees en bois
NO995132D0 (no) Fremgangsmåte for reduksjon av fibrinogen
ATE75478T1 (de) Gametozide.
SE8405083L (sv) Sett for behandling av tre
SU1208623A1 (ru) Препарат для лечения копытной гнили "формакаст"
KR860006065A (ko) 본체자면크기(body face size)치환에 따른 문자수식제어방식
RO81145A2 (ro) Dispozitiv pentru e0tractia titeiului prin eruptie artificiala
SE8306929D0 (sv) Sett att styra en process med dodtid
ATE96667T1 (de) Verwendung von heterocyclischen verbindungen zur behandlung von depressionen.
ES8603168A1 (es) Metodo para fabricar una composicion farmaceutica util para tratar el parkinsonismo
IT1173588B (it) Agonista selettivo di ricettori d-2 di dopamina

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment